Late‐onset behavioral variant of frontotemporal lobar degeneration versus Alzheimer's disease: Interest of cerebrospinal fluid biomarker ratios
Open Access
- 27 June 2015
- journal article
- Published by Wiley in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
- Vol. 1 (3) , 371-379
Abstract
Introduction: Cerebrospinal fluid (CSF) biomarker ratios were never evaluated in late‐onset (>65 years) behavioral variant of frontotemporal lobar degeneration (bvFTLD) versus Alzheimer's disease (AD).Methods: A retrospective monocentric study on 44 clinically suspected amnestic AD or bvFTLD patients with onset after 65 years and available CSF and clinical data.Results: The final clinical diagnosis was AD (n = 28; 64%), late‐onset bvFTLD (n = 14; 32%), and others (n = 2; 4%). Applying the CSF cutoff total‐tau/Aβ1–42 of 1.06, all the bvFTLD were in the FTLD range (1.06, AD/AD) or in the FTLD range (<1.06, AD/FTLD); CSF biomarkers were significantly different in these three groups, but not neuroradiological features or presence of episodic memory deficit.Discussion: Late‐onset bvFTLD is underdiagnosed. The available CSF biomarker ratio cutoff need further improvement and overestimated late‐onset bvFTLD but could potentially differentiate it from AD, notably in case of conflicting results.Keywords
This publication has 22 references indexed in Scilit:
- CSF biomarkers cutoffs: the importance of coincident neuropathological diseasesActa Neuropathologica, 2012
- Cerebrospinal Fluid Collection Tubes: A Critical Issue for Alzheimer Disease DiagnosisClinical Chemistry, 2012
- Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementiaBrain, 2011
- Visual assessment of posterior atrophy development of a MRI rating scaleEuropean Radiology, 2011
- Pathological correlates of frontotemporal lobar degeneration in the elderlyActa Neuropathologica, 2010
- Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementiasJournal of Neurology, Neurosurgery & Psychiatry, 2010
- CSF biomarkers in frontotemporal lobar degeneration with known pathologyNeurology, 2008
- Improved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSFNeurology, 1999
- Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal agingAmerican Journal of Roentgenology, 1987